SiDx, Inc.

Seattle, WA · Founded 2017 · CIK 0001714792 · Medtech · Private

Silicon photonic biosensor for detecting and quantifying anti-ABO antibodies in blood samples

sidx.com →
Grants
$2.7M
4 awards
Sector median: 1
Raised
$2.6M
3 Form D · Oct 2021
60 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,549,998
Federal grantDepartment of Health and Human Services · Phase II · Silicon Photonic Blood Typing$223,906
Private capital raisedForm D · SEC$715,000
Federal grantDepartment of Health and Human Services · Phase II · Silicon Photonic Blood Typing$1,466,814
Federal grantDepartment of Health and Human Services · Phase II · Silicon Photonic Blood Typing$720,701
Federal grantDepartment of Health and Human Services · Phase I · Silicon Photonic Detection of anti-ABO Antibodies$253,054
Private capital raisedForm D · SEC$305,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1134FOXO TECHNOLOGIES INC.—$15M
1135StimuSIL, Inc.—$2.3M
1136THEROMICS INC.—$2.3M
1137SiDx, Inc.—$2.6M
1138Cadense, Inc.—$2.1M
1139TAURUS DIAGNOSTICS, INC——
1140SFC FLUIDICS, INC.—$2.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Jill JohnsenDirector · Executive Officer
  • Eric LarsenDirector · Executive Officer
  • Caroline PopperDirector
  • Dan RatnerDirector · Executive Officer
  • Daniel RatnerDirector
  • Bryan WhiteDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.